Trials / Completed
CompletedNCT01780701
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer
Imaging Prostatic Lipids to Distinguish Aggressive Prostate Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 66 (actual)
- Sponsor
- OHSU Knight Cancer Institute · Academic / Other
- Sex
- Male
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
A prostate cancer diagnosis starts a list of events that often leads to fast-moving treatment, thought by many to result in vast over-treatment of this disease. So, discovery of different diagnostic methods that allow clinicians to identify slow-growing from potentially fast-growing disease prior to or at the time of prostate biopsy could result in early and suitable treatment for men at greatest risk, while greatly decreasing the number of biopsies, surgical procedures, hormonal and chemotherapeutic treatments, cost, and patient worry, for those with more slow-growing disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Magnetic Resonance Spectroscopy Imaging with rectal probe |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2016-01-01
- Completion
- 2017-03-01
- First posted
- 2013-01-31
- Last updated
- 2017-04-27
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01780701. Inclusion in this directory is not an endorsement.